Enlivex Therapeutics financial statements

엔라이벡스 테라퓨틱스NASDAQ:ENLV · Nasdaq · Healthcare · sector #17
$0.3402-6.02%
2026-10-06 close

Enlivex Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$16M.

Reported results

Enlivex Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy